V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20130428 | 20178731 | 1.74 | 62 | null | 2022-01-27 | 2022-02-12 | null | 02 | null | SUNITINIB | 100859039 |
| 20130468 | 20178732 | 0 | 89 | null | null | 2018-06-01 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101289378 |
| 20131694 | 20178733 | 1.72 | 0 | null | 2021-01-19 | 2021-09-29 | null | 02 | null | CISPLATIN + ETOPOSIDE | 101227084 |
| 20131904 | 20178735 | 1.7 | 85.8 | Curative (C) | 2021-11-22 | 2021-11-28 | null | 02 | Y | CETUXIMAB + ENCORAFENIB | 100112547 |
| 20131959 | 20178736 | 1.8 | 95.91 | Curative (C) | 2019-06-23 | 2019-06-23 | null | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 101090541 |
| 20132270 | 20178737 | 1.67 | 0 | null | 2021-10-01 | 2021-12-04 | null | 02 | null | ENZALUTAMIDE | 101458958 |
| 20132689 | 20178738 | 0 | null | Palliative (P) | 2018-04-02 | 2018-05-20 | null | 99 | N | CISPLATIN | 100298501 |
| 20133526 | 20178739 | 1.52 | 66 | null | 2021-03-17 | 2021-04-07 | null | 02 | null | BEVACIZUMAB | 101369305 |
| 20134721 | 20178740 | 1.58 | 53.5 | Palliative (P) | 2019-07-07 | 2019-07-27 | LUTETIUM-177 | 2 | N | SUNITINIB | 100284389 |
| 20134872 | 20178741 | 1.67 | 104.9 | null | 2016-06-29 | 2016-07-09 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101696186 |
| 20141651 | 20178742 | 1.72 | null | Palliative (P) | null | 2017-06-09 | null | 02 | N | ENZALUTAMIDE | 100425644 |
| 20141745 | 20178743 | 1.69 | 75.4 | null | null | 2019-12-17 | null | 02 | null | SUNITINIB | 101465889 |
| 20142915 | 20178744 | 1.69 | 59 | Palliative (P) | 2022-02-21 | 2022-02-21 | null | 02 | N | PEMBROLIZUMAB | 100097838 |
| 20143244 | 20178745 | 1.78 | 74.9 | Palliative (P) | 2019-02-07 | 2019-06-21 | null | N | N | SCALOP-2 TRIAL | 100190619 |
| 20143370 | 20178746 | 1.6 | 59.5 | Neo-adjuvant (N) | 2017-01-13 | 2017-01-31 | null | N | N | NOT MATCHED | 100028118 |
| 20143988 | 20178747 | 1.68 | 0 | null | 2019-11-01 | 2019-11-03 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 101187221 |
| 20144687 | 20178748 | 1.84 | 78.6 | null | null | 2018-03-09 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100262936 |
| 20144867 | 20178749 | 1.76 | null | Palliative (P) | 2019-11-12 | 2019-11-12 | null | 02 | N | CISPLATIN + ETOPOSIDE | 100413733 |
| 20147170 | 20178750 | 1.81 | null | Palliative (P) | 2020-01-20 | 2020-04-24 | LUTETIUM-177 | 02 | N | CETUXIMAB + ENCORAFENIB | 101789225 |
| 20148182 | 20178751 | 1.74 | 51.9 | Palliative (P) | 2019-03-17 | 2019-03-22 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101627462 |
| 20148558 | 20178752 | 1.76 | 0 | Palliative (P) | 2019-10-08 | 2020-08-08 | null | 02 | N | LUTETIUM-177 | 101213518 |
| 20150859 | 20178754 | 1.82 | 90 | null | null | 2021-08-17 | null | 02 | null | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101533733 |
| 20152042 | 20178755 | 0 | 55.3 | Curative (C) | 2018-11-28 | 2018-12-14 | Cisplatin + Radiotherapy | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100555245 |
| 20152086 | 20178756 | 0 | 97.6 | Neo-adjuvant (N) | 2022-02-25 | 2022-02-27 | BCG Intravesical | 02 | N | HYDROXYCARBAMIDE | 100729830 |
| 20153599 | 20178757 | 1.57 | 82 | 03 | null | 2016-11-28 | MITOMYCIN | 2 | null | IRINOTECAN + MDG + PANITUMUMAB | 101454725 |
| 20154024 | 20178758 | 1.72 | 63.5 | null | 2020-04-06 | 2020-04-22 | Hepatoblastoma SR PLADO | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101388079 |
| 20154786 | 20178760 | 1.65 | 59 | Neo-adjuvant (N) | 2019-07-12 | 2019-07-21 | Niraparib | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100122535 |
| 20155475 | 20178761 | 1.83 | 76.5 | Palliative (P) | 2021-06-25 | 2021-07-04 | MITOMYCIN | 2 | N | HYDROXYCARBAMIDE | 101204404 |
| 20155759 | 20178762 | 1.55 | 68.2 | Disease modification (D) | 2020-05-15 | 2020-05-31 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 2 | N | CAP + RT | 101793421 |
| 20157177 | 20178763 | 1.65 | 71.3 | Curative (C) | 2022-04-08 | 2022-04-17 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | Y | N | CVAMP | 101243634 |
| 20157596 | 20178764 | null | 64.3 | Palliative (P) | 2018-02-26 | 2018-02-26 | Gemcitabine + Oxaliplatin | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100080821 |
| 20159094 | 20178765 | 1.55 | 62.8 | null | 2021-05-17 | 2021-05-17 | Fluorouracil + Folinic + RT Bossett | 01 | null | DOXORUBICIN | 101121232 |
| 20159370 | 20178766 | 1.52 | 85.4 | Palliative (P) | 2020-09-15 | 2021-04-30 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | null | IPILIMUMAB + NIVOLUMAB | 101429125 |
| 20163011 | 20178768 | 1.79 | 77.2 | Neo-adjuvant (N) | null | 2019-08-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 1 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE | 100465565 |
| 20164336 | 20178769 | 1.89 | 87.3 | null | 2018-11-24 | 2018-11-24 | CARBOPLATIN + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | TOPOTECAN | 101712263 |
| 20169180 | 20178772 | 1.82 | 77.9 | Curative (C) | 2018-02-09 | 2018-02-25 | CARBOPLATIN + CETUXIMAB + FU | 02 | null | INTERAACT TRIAL | 100813839 |
| 20171685 | 20178773 | 1.52 | 87 | null | 2022-04-17 | 2022-05-05 | Cisplatin +FU +Trastuzumab - Load | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100753451 |
| 20172887 | 20178775 | 1.69 | null | Palliative (P) | 2021-11-03 | 2021-11-12 | Niraparib | 02 | N | UKALL60+ | 101667430 |
| 20173337 | 20178776 | 1.6 | 93 | Curative (C) | 2021-11-16 | 2021-12-27 | Cabazitaxel | 02 | null | BEVACIZUMAB + CAPECITABINE | 100025739 |
| 20175290 | 20178777 | 1.77 | 84.4 | null | 2021-01-31 | 2021-04-20 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | DOCETAXEL + NINTEDANIB | 101297314 |
| 20180926 | 20178779 | 1.79 | 88 | Palliative (P) | 2019-09-18 | 2020-01-09 | CARBOPLATIN + VINORELBINE | 02 | N | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 100350853 |
| 20184308 | 20178782 | 1.79 | 65.8 | 03 | 2022-03-12 | 2022-03-29 | Cisplatin +FU +Trastuzumab - Maint | 02 | N | FOXTROT TRIAL | 100669532 |
| 20184820 | 20178783 | 0 | null | Curative (C) | 2016-08-02 | 2016-08-15 | FOXTROT TRIAL | 02 | N | PHITT D SIOPEL-4 (A1, A2, A3) | 100129984 |
| 20185965 | 20178784 | 1.56 | 62.5 | Curative (C) | 2021-05-14 | 2022-01-23 | Atezolizumab | 02 | Y | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101692704 |
| 20186389 | 20178785 | 1.56 | 11.1 | null | 2019-04-18 | 2020-05-19 | Binimetinib + Encorafenib | 02 | null | IBRUTINIB | 101404371 |
| 20191722 | 20178787 | 1.75 | 86.1 | null | 2019-09-05 | 2019-09-07 | Rucaparib | 02 | null | TOPOTECAN | 100789396 |
| 20192517 | 20178788 | null | 0 | null | 2018-07-09 | 2020-04-27 | Fulvestrant + Ribociclib | 02 | N | EPIRUBICIN | 100811264 |
| 20193552 | 20178790 | 1.52 | null | Palliative (P) | 2019-04-20 | 2020-02-20 | CHOP R - 21 days | 02 | Y | OXALIPLATIN + MDG + PANITUMUMAB | 100636346 |
| 20193638 | 20178791 | 1.8 | 57 | Curative (C) | 2020-01-02 | 2020-02-14 | Eribulin | 02 | N | IPILIMUMAB + NIVOLUMAB | 101825471 |
| 20193816 | 20178792 | 1.83 | 15.9 | Curative (C) | 2019-12-19 | 2019-12-20 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | CISPLATIN + CYTARABINE + ETOPOSIDE | 100567206 |